Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Discontinuation of aspirin as primary prevention and cardiovascular events in diabetes
TCTR20220114002Completed
- Sponsor
- N/A
- Start
- Jan 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of aspirin in type 2 diabetes mellitus (T2DM) and cardiac morbidity, sponsored by N/A. Started Jan 2018; status: completed.
02
Drugs
aspirin
03
Conditions
type 2 diabetes mellitus (T2DM)cardiac morbidity
Beyond the preview
Go deeper on TCTR20220114002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220114002.